Musculoskeletal disorders are The #1 Global Health Burden affecting the world today. 

This Health Burden is compounded by the problems of:

• Accessibility of care - only 27% of the global population has health insurance coverage, mostly in high and middle income countries.

• Absence of scalable solutions - Common solutions include bedrest, painkillers, and surgery, usually provided by local doctors with a limited access to optimal treatment concepts.

• Disproportionate treatment delivery - A small group of high-risk patients consume the majority of health-care spending. Early intervention can prevent the recurrence of problems. 

This Health Burden trend can change.

DBC Global is one of the most experienced companies addressing the challenges in this market with an evidence-based treatment approach for treating high-risk MSK patients. We have invested  over 17 million euros on developing, validating, and implementing these treatment concepts into a scalable clinical practice.

With our new mobile and digital solution, we can make these concepts available to millions of people.

DBC founder, Medical Doctor, and Adjunct Professor Simo Taimela has been involved in the following studies supporting the DBC approach:

• 5 Randomized Controlled Trial studies for active treatment of chronic back/neck pain.

• 22 Randomized Controlled Trial studies for other MSK and topics related to return to work and work-ability.

• Altogether over 150 publications regarding MSK and other related topics, such as MSK and the impact on the ability to work.

• The majority of these articles have been published in the top medical journals such as The Lancet, Spine, BMJ and BJSM.

Additionally, DBC’s own quality assurance database is on par with the above-mentioned studies, resolving 90% of the MSK problems and generating up to 40% savings in direct healthcare costs. DBC COE (Center of Excellence) Clinics have operated in 22 countries, providing the same high quality results in all locations.